2017
Neoadjuvant systemic therapy in breast cancer (NeST) – a prospective, multicentre audit
Stuart McIntosh on behalf of the Northern Ireland Surgical Research Collaborative and the Mammary Fold Academic & Research Committee
Publications (full manuscripts / conference paper abstracts)
-Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study. Fatayer H et al. British Journal of Surgery. May 2022.
-The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making. Whitehead I et al. BMC Cancer 21:90. 2021
-The NeST (neoadjuvant systemic therapy in breast cancer) study- protocol for a prospective multicentre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancer. Irwin GW et al. International Journal of Surgery Protocols. Nov 2019
-National utilisation of neoadjuvant systemic therapy and impact on surgical treatment – a prospective multicentre cohort study. McIntosh SA et al. Cancer Research. Feb 2020.
Presentations (oral or poster)
-NeST trial data (ABS & UKBCG guidance on NACT section)
Presented at the 2022 ABS conference
-National utilisation of neoadjuvant systemic therapy and impact on surgical treatment – a prospective multicentre cohort study
Presented at the forty-second Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2019 Dec; San Antonio, TX
-Surgical outcomes following neoadjuvant chemotherapy – a UK national prospective multi-centre cohort study
Presented at the 2020 UK Interdisciplinary Breast cancer Symposium, Birmingham
Presented at the 2020 UK Interdisciplinary Breast cancer Symposium, Birmingham
-NEST (neoadjuvant chemotherapy: management of axilla and trials session)
Presented at the 2019 ABS conference
-Utilisation and short term outcomes of neoadjuvant chemotherapy for breast cancer: a prospective national multicenter study
5th World Congress on Controversies in Breast Cancer, San Francisco, USA, September 2019 (oral presentation)
-The NeST (neoadjuvant systemic therapy in breast cancer) study
Melbourne Joint International Breast Congress, October 2018